Source:http://linkedlifedata.com/resource/pubmed/id/18221988
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-9-29
|
pubmed:abstractText |
Systemic sclerosis (SSc) is a chronic connective tissue disease characterized by vascular damage, autoimmunity, and excessive collagen deposition. Despite advances in disease-specific treatment of other rheumatologic diseases, disease-targeted treatment in SSc continues to be elusive. In this review, our goal was to place the contemporary immunobiology of SSc in the perspective of clinical medicine.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1532-866X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
132-60
|
pubmed:meshHeading | |
pubmed:year |
2008
|
pubmed:articleTitle |
The immunobiology of systemic sclerosis.
|
pubmed:affiliation |
Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, California 95616, USA.
|
pubmed:publicationType |
Journal Article,
Review
|